TNF and cystic fibrosis: In vitro studies have shown that CF have anti-inflammatory properties and can reduce tumour necrosis factor-α (TNF-α) from inducing an upregulation of vascular endothelial growth factor activity [64] and inhibit nuclear factor-kappa beta activation [65].